he annual Nanovax Research Symposium is centered on bringing nanoparticle-based research on the development of next-generation vaccines and therapeutics to patients within a Systems Framework. As the recent SARS-CoV-2 pandemic revealed, the health of people and global social-ecological systems are closely intertwined, and so the solutions to emergent diseases must be able to be effective within the social-ecological system in which humans and animals co-exist. The foundation of the symposium is based on communication, coordination, and collaboration to advance equitable health solutions that span the continuum from basic research through formulation, testing, and manufacturing and regulatory protocols.

The event will bring together experts from all corners of vaccine and therapeutic research to advance promising and robust next-generation nanovaccines and nanotherapeutics through regulatory approvals and to clinical trials. The program will emphasize a transdisciplinary approach to transform the design and manufacturing of nanovaccines and nanotherapeutics that integrates nanotechnology, materials science, immunology, oncology, neuroscience, microbiology, clinical science, and social science.